Clinical outcomes observed with Rivaroxaban versus low molecular weight heparin (Enoxaparin) for thrombo-prophylaxis following total knee arthroplasty: a meta-analysis
Our analysis showed that rivaroxaban when used as thrombo-prophylaxis following TKA, significantly reduced thrombotic outcomes when compared to LMWH. However, the risks of bleeding events including major and minor bleeding events were significantly increased in comparison to LMWH. Therefore, further larger studies should be able to confirm our hypothesis.
Authors
- Yi Peng (ORCID: https://orcid.org/0000-0001-7830-4694)
- Yaxiong Dai
- Sha Xia
Institutions
- Huanggang Normal University (CN)
- Huanggang Central Hospital (CN)
Publication Details
- Journal
- BMC Cardiovascular Disorders
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1186/s12872-025-05495-w
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00